Document Type : Letter to the Editor
Authors
Multiple Sclerosis Research Center, Tehran University of Medical Sciences, Tehran, Iran
Abstract
-
Keywords
- Clerico M, Artusi CA, Liberto AD, Rolla S, Bardina V, Barbero P, et al. Natalizumab in multiple sclerosis: Long-term management. Int J Mol Sci 2017; 18(5): 940.
- Stosic M, De JP, McCarthy J, Hutton G, Rivera V. Immune thrombocytopenic purpura in a patient with multiple sclerosis treated with natalizumab. Neurology 2011; 77(5): 505-7.
- Midaglia L, Rodriguez RM, Munoz-Garcia D. Severe haematological complications during treatment with natalizumab. Mult Scler 2012; 18(11): 1644-6.
- Cachia D, Izzy S, Berriosmorales I, Ionete C. Drug-induced thrombocytopenia secondary to natalizumab treatment. BMJ Case Rep 2014; 2014: bcr2013203313.
- Rini AM, Clerici VT, Rinaldi E, Modesto M, Pastore D, Confalonieri PA, et al. Severe thrombocytopenia during Natalizumab therapy: A case report. J Neurol Sci 2020; 409: 116587.
)